Passport Capital’s Bristol-Myers Squibb BMY Stock Holding History

Passport Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,374,032	Closed	-$87.8M	–	143
2016 Q1	$87.8M	Sell	1,374,032 -584,040	-30%	-$36.8M	1.43%	16
2015 Q4	$135M	Buy	1,958,072 +1,556,819	+388%	+$103M	2.24%	9
2015 Q3	$23.8M	Buy	+401,253	New	+$25.5M	0.42%	33

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Passport Capital's BMY Position: Q2 2016 in Review

Passport Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 1,374,032 shares — an estimated $87.8M sold.

Passport Capital first reported a position in BMY in Q3 2015 and held it in 3 quarters. The position peaked at $135M in Q4 2015. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

Passport Capital reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
Passport Capital sold 1,374,032 Bristol-Myers Squibb shares in Q2 2016, an estimated $87.8M.
Passport Capital first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 3 quarters.
Passport Capital's Bristol-Myers Squibb position peaked at $135M in Q4 2015.
1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on Passport Capital's 13F filing for Q2 2016, filed 15 Aug 2016.